Status:

TERMINATED

BONEBRIDGE Bone Conduction Implant in Adults

Lead Sponsor:

Med-El Corporation

Conditions:

Hearing Loss, Conductive

Hearing Loss, Mixed

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Approximately thirty subjects with mixed or conductive hearing loss, meeting FDA-cleared candidacy criteria for the BONEBRIDGE, will be implanted and followed for three (3) months post-activation to a...

Eligibility Criteria

Inclusion

  • Adults, 18 years of age or older at the time of implantation
  • Conductive or mixed hearing loss, defined as:
  • Conductive hearing loss with pure-tone average (PTA) for bone conduction thresholds better than or equal to 25 dB at 500, 1000, 2000 and 3000 Hz
  • Mixed hearing loss with PTA for bone conduction thresholds better than or equal to 45dB at 500, 1000, 2000, and 3000 Hz
  • Air-bone gap greater than or equal to 30 dB at 500, 1000, 2000, and 3000 Hz
  • Ability to benefit from amplification as defined by a monosyllabic (CNC) word score of 30% correct or better
  • Bilateral BONEBRIDGE can be considered if the difference in PTA for bone conduction thresholds is 10 dB or less between the right and left ears
  • Prior experience with acoustic or bone conduction hearing aids, unless candidate is unable to wear amplification for medical reasons
  • Able to complete testing materials in English
  • CT scan indicating the patient's anatomy is adequate to enable placement of the implant
  • Ability to undergo general anesthesia
  • Appropriate motivation and expectation levels
  • Stated willingness to comply with all study procedures for the duration of the study

Exclusion

  • Evidence that hearing loss is retrocochlear in origin
  • Skin or scalp condition precluding use of external audio processor
  • Suspected cognitive impairment or organic brain dysfunction

Key Trial Info

Start Date :

August 26 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 4 2022

Estimated Enrollment :

9 Patients enrolled

Trial Details

Trial ID

NCT03859648

Start Date

August 26 2019

End Date

November 4 2022

Last Update

May 30 2024

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

The Ohio State Wexner Medical Center University

Columbus, Ohio, United States, 43081

2

The Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104

3

London Health Sciences Centre

London, Ontario, Canada, N6A 5A5